Ausgabe 6/2021
Inhalt (18 Artikel)
Consensus on the secondary prevention of primary liver cancer
Yuemin Nan, Xiaoyuan Xu, Yanhang Gao, Rongqi Wang, Wengang Li, Ming Yang, Lingdi Liu, Zhongping Duan, Jidong Jia, Lai Wei, Hui Zhuang, Huiguo Ding, Zhongping Duan, Jiangao Fan, Qinmao Fang, Yanhang Gao, Peng Hu, Jidong Jia, Wengang Li, Jingfeng Liu, Junqi Niu, Yuemin Nan, Jia Shang, Rongqi Wang, Lai Wei, Yanyan Yu, Yuguo Zhang, Suxian Zhao, Jian Zhou, Weifeng Zhao, Xiaoyuan Xu, Chuanmiao Xie, Wen Xie, Ming Yang, Hui Zhuang
Are herbals more hepatotoxic than prescription medications?
Vincent L. Chen, Robert J. Fontana
Gut microbiota alteration in hepatobiliary diseases: cause-and-effect relationship
Xiaoyan Guo, Yanmei Jiao, Jinwen Song, Fu-Sheng Wang
Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids
Gayatri Ramakrishna, Preedia E. Babu, Ravinder Singh, Nirupma Trehanpati
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis
Xiaoning Wu, Jia Hong, Jialing Zhou, Yameng Sun, Lei Li, Wen Xie, Hongxin Piao, Xiaoyuan Xu, Wei Jiang, Bo Feng, Yongpeng Chen, Mingyi Xu, Jilin Cheng, Tongtong Meng, Bingqiong Wang, Shuyan Chen, Yuanyuan Kong, Xiaojuan Ou, Hong You, Jidong Jia
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Dong Hyun Sinn, Seung Up Kim
Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study
Hui-Hui Liu, Ye-Xuan Cao, Jing-Lu Jin, Yuan-Lin Guo, Cheng-Gang Zhu, Na-Qiong Wu, Ying Gao, Rui-Xia Xu, Qian Dong, Ming-Hua Zheng, Jian-Jun Li
Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease
Ji Won Yoon, Min Joo Kim, Goh-Eun Chung, Jong In Yang, Jeong Yoon Yim, Jin Ju Kim, Sun Mie Kim, Min-Sun Kwak
A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?
Shujie Dong, Huihong Qi, Yan Li, Peng Men, Maiwujudan Alifu, Yatong Zhang, Yongjun Li, Rongsheng Zhao
‘First week’ is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure
Ashok Choudhury, Rajan Vijayaraghavan, Rakhi Maiwall, Manoj Kumar, Zhongping Duan, Chen Yu, Saeed Sadiq Hamid, Wasim Jafri, Amna Subhan Butt, Harshad Devarbhavi, Qin Ning, Ke Ma, Soek-Siam Tan, Akash Shukla, Radhakrishna Dhiman, Ajay Duseja, Sunil Taneja, C. E. Eapen, Ashish Goel, Sombat Treeprasertsuk, Mamun Al-Mahtab, Hasmik Ghazinyan, Dong Joon Kim, Manoj K. Sahu, Guan Huei Lee, Laurentius A. Lesmana, Rinaldi Cosmas Lesmana, Samir Shah, Zaigham Abbas, Jose D. Sollano, P. N. Rao, Anand Kulkarni, Gamal Shiha, Ananta Shrestha, AKadir Dokmeci, Man Fung Yuen, Diana Alcantara Payawal, Kemal Fariz Kalista, V. G. Mohan Prasad, George K. Lau, Fazal Karim, Priyanka Jain, Guresh Kumar, Vinod Arora, Viniyendra Pamecha, Piyush Sinha, Shiv K. Sarin
Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction
Nidhi Nautiyal, Deepanshu Maheshwari, Dinesh Mani Tripathi, Dhananjay Kumar, Rekha Kumari, Suchi Gupta, Sachin Sharma, Sujata Mohanty, Anupama Parasar, Chhagan Bihari, Subhrajit Biswas, Archana Rastogi, Rakhi Maiwall, Anupam Kumar, Shiv Kumar Sarin
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
Fanping Meng, Jinfang Zhao, Anthony Tanoto Tan, Wei Hu, Si-Yu Wang, Jiehua Jin, Juan Wu, Yuanyuan Li, Lei Shi, Jun-Liang Fu, Shuangjie Yu, Yingjuan Shen, Limin Liu, Junqing Luan, Ming Shi, Yunbo Xie, Chun-Bao Zhou, Regina Wanju Wong, Wai Lu-En, Sarene Koh, Antonio Bertoletti, Tingting Wang, Ji-Yuan Zhang, Fu-Sheng Wang
Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis
Lun-Jie Yan, Sheng-Yu Yao, Guang-Xiao Meng, Kai-Xuan Liu, Hai-Chao Li, Zi-Niu Ding, Zhao-Ru Dong, Jian-Guo Hong, Zhi-Qiang Chen, Tao Li
Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines
Wei Teng, Ting-Tsung Chang, Hwai-I Yang, Cheng-Yuan Peng, Chien-Wei Su, Tung-Hung Su, Tsung-Hui Hu, Ming-Lung Yu, Hung-Chih Yang, Jaw-Ching Wu
Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial
Ming Shi, Yuan-Yuan Li, Ruo-Nan Xu, Fan-Ping Meng, Shuang-Jie Yu, Jun-Liang Fu, Jin-Hua Hu, Jing-Xin Li, Li-Feng Wang, Lei Jin, Fu-Sheng Wang
Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery
Burak Özbaş, Onur Keskin, Hartmut Hecker, Irfan Karahan, Cansu Özbaş, Çağdaş Kalkan, Aysun Kartal, Fatih Oğuz Önder, Burcu Kahveci Öncü, Genco Gençdal , Murat Akyildiz, Fulya Günşar, Ramazan Idilman, Karin Weissenborn, Ömer Özütemiz, Cihan Yurdaydin
Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury
Yi-Shin Huang, Ting-Tsung Chang, Cheng-Yuan Peng, Gin-Ho Lo, Chao-Wei Hsu, Chi-Tan Hu, Yi-Hsiang Huang
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
Huei-Ru Cheng, Hung-Chih Yang, Su-Ru Lin, Ta-Yu Yang, You-Yu Lin, Tung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, Jia-Horng Kao